01/03/2025 6:25 PM | SABBY MANAGEMENT, LLC (Filed by) TransCode Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/30/2024 4:08 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
12/19/2024 3:48 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
12/17/2024 11:15 PM | TransCode Therapeutics (Filer)
| Form EFFECT | |
12/12/2024 3:15 PM | TransCode Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/06/2024 4:05 PM | TransCode Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/02/2024 3:27 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2024 3:21 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/25/2024 6:54 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 3:34 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
11/06/2024 3:05 PM | 3i, LP (Filed by) TransCode Therapeutics (Subject)
| Form SC 13G/A | |
|
10/28/2024 3:02 PM | TransCode Therapeutics (Filer)
| Form DEF 14A | |
10/15/2024 4:23 PM | TransCode Therapeutics (Filer)
| Form PRE 14A | |
09/27/2024 3:02 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2024 5:02 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 4:04 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 3:45 PM | TransCode Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 8:01 AM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 7:18 AM | TransCode Therapeutics (Filer)
| Form 424B5 | |
07/22/2024 3:10 PM | TransCode Therapeutics (Filer)
| Form 424B5 | |
06/14/2024 7:00 AM | TransCode Therapeutics (Filer)
| Form 8-K/A | |
06/13/2024 4:06 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 7:45 AM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
05/13/2024 4:08 PM | TransCode Therapeutics (Filer)
| Form DEFA14A | |
05/10/2024 3:45 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:51 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 7:12 PM | Lind Global Fund II LP (Filed by) TransCode Therapeutics (Subject)
| Form SC 13G/A | |
01/31/2024 3:33 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2024 3:45 PM | TransCode Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |